[Transtracheal catheter and liquid oxygen: 5 years of experience].
We studied clinical tolerance, complications, change in pulmonary function test results, arterial gasometrics, hemoglobin (Hb), 6 minute stress tests (6 wt) and subjective perception of dyspnea assessed on a visual analog scale (VAS) in a group of 18 patients (17 with obstructive disease and one with restrictive disease). These patients had previously been enrolled in a home oxygen therapy (HOT) program to deliver continuous oxygen therapy through nasal prongs, and had accepted portable oxygen therapy delivered by transtracheal catheter (TTC) from 1988 until 1993. Tolerance was good, there were no lethal complications of TTC, and excellent compliance with the prescribed HOT was achieved. Lung function test results worsened, while Hb and PaO2 improved and significant oxygen savings (50%) were achieved. The 6 wt test results had not worsened at the end of the first year but did so significantly at the end of the third year, in spite of a relative preservation of lung function. Dyspnea assessed on a VAS was not seen to worsen. We conclude that tolerance of the method was good and that no relevant complications occurred. HOT by TTC did not prevent worsening of bronchial obstruction. Oxygenation of patients was better, as shown by the decrease in Hb and the improvement in PaO2 at the end of the first year of monitoring. Changes in 6 wt showed that in order to achieve greater benefit from HOT by TTC, patients should follow a pulmonary rehabilitation program.
Domingo
C
C
Servicio de Neumología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona.
Coll
R
R
Izquierdo
J
J
Roig
J
J
Klamburg
J
J
Domingo
E
E
Moreno
J A
JA
Morera
J
J
D000368:Aged; D002404:Catheterization / Q000295:instrumentation; D004417:Dyspnea / Q000175:diagnosis; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006699:Home Care Services; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications; D008173:Lung Diseases, Obstructive / Q000209:etiology / Q000503:physiopathology / Q000534:rehabilitation*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000008:administration & dosage; D010102:Oxygen Inhalation Therapy / Q000295:instrumentation*; D010349:Patient Compliance; D012129:Respiratory Function Tests; D012907:Smoking / Q000009:adverse effects; D013997:Time Factors
D010100:Oxygen
Catéter transtraqueal y oxígeno líquido: 5 años de experiencia.